Stockscreener 앱 받기
2.00
11.11%
0.20
시간 외 거래:
2.00
Climb Bio Inc 주식(CLYM)의 최신 뉴스
Will Climb Bio Inc. stock deliver shareholder valueJuly 2025 Closing Moves & Weekly High Return Forecasts - newser.com
How to integrate Climb Bio Inc. into portfolio analysis toolsMarket Activity Report & Real-Time Stock Price Movement Reports - newser.com
Climb Bio Inc. recovery potential after sell offTake Profit & Growth Focused Stock Pick Reports - newser.com
HC Wainwright Initiates Climb Bio at Buy With $9 Price Target - MarketScreener
Climb Bio Unveils Promising Preclinical Data for CLYM116 - MSN
Can technical indicators confirm Climb Bio Inc.’s reversalEarnings Recap Summary & Fast Entry High Yield Tips - newser.com
Leading vs lagging indicators on Climb Bio Inc. performanceJuly 2025 Intraday Action & Safe Entry Point Alerts - newser.com
What technical models suggest about Climb Bio Inc.’s comebackJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
Institutional scanner results for Climb Bio Inc.July 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
Visual analytics tools that track Climb Bio Inc. performanceQuarterly Profit Report & Community Verified Watchlist Alerts - newser.com
Relative strength of Climb Bio Inc. in sector analysisJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com
Climb Bio Inc. stock volume spike explainedMarket Movement Recap & AI Forecasted Entry and Exit Points - newser.com
Climb Bio (NASDAQ:CLYM) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Climb Bio Inc. stock prediction for this week2025 Sector Review & Safe Entry Zone Tips - newser.com
How to use Fibonacci retracement on Climb Bio Inc.Market Trend Report & Weekly Top Stock Performers List - newser.com
Can Climb Bio Inc. stock outperform in 2025 bull market2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com
Sector ETF performance correlation with Climb Bio Inc.Short Setup & Real-Time Market Trend Scan - newser.com
Climb Bio, Inc. (NASDAQ:CLYM) Sees Significant Drop in Short Interest - MarketBeat
Climb Bio Experiences Measurable Shift In Market Positioning - Kalkine Media
Climb Bio (NASDAQ:CLYM) Rating Increased to Hold at Wall Street Zen - Defense World
Climb Bio (NASDAQ:CLYM) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Analyzing Climb Bio Inc. with multi timeframe charts2025 Macro Impact & Consistent Income Trade Ideas - newser.com
Oppenheimer Maintains Climb Bio(CLYM.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛
Climb Bio, Inc. (NASDAQ:CLYM) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Can Climb Bio Inc. recover in the next quarterMarket Risk Report & Reliable Trade Execution Plans - newser.com
Climb Bio to be Added to the Nasdaq Biotechnology Index - FinancialContent
Climb Bio appoints Susan Altschuller as new CFO By Investing.com - Investing.com Nigeria
Climb Bio appoints Susan Altschuller as chief financial officer By Investing.com - Investing.com Nigeria
Former bluebird CEO picked to lead Inventiva - biocentury.com
Climb Bio appoints Susan Altschuller as chief financial officer - Investing.com India
Climb Bio Appoints New CFO Susan Altschuller - TipRanks
Climb Bio Names Dr. Susan Altschuller CFO - MarketScreener
Leerink Partners Maintains Climb Bio(CLYM.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛
Climb Bio appoints Susan Altschuller, Ph.D., MBA as chief financial officer - MarketScreener
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer - markets.businessinsider.com
Climb Bio appoints Susan Altschuller as new CFO - Investing.com
From $8.7B Cerevel Deal to Climb Bio: Biotech Veteran Susan Altschuller Takes CFO Role as Trials Advance - Stock Titan
1.11%
자본화:
|
볼륨(24시간):